about
sameAs
The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessmentDisability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.A systematic review of the global distribution and availability of prevalence data for bipolar disorder.Should global burden of disease estimates include depression as a risk factor for coronary heart disease?Mental disorders as risk factors: assessing the evidence for the Global Burden of Disease Study.Global epidemiology of mental disorders: what are we missing?The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010.Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 Study.A population-based study of Australian twins with melanoma suggests a strong genetic contribution to liabilityThe Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures.Global prevalence of anxiety disorders: a systematic review and meta-regression.Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature.How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.Challenging the myth of an "epidemic" of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010.The global burden of anxiety disorders in 2010.The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010.The epidemiology and global burden of autism spectrum disorders.Social correlates of mental, neurological, and substance use disorders in China and India: a review.The regional distribution of anxiety disorders: implications for the Global Burden of Disease Study, 2010.Males' mental health disadvantage: An estimation of gender-specific changes in service utilisation for mental and substance use disorders in Australia.In an open publishing house not so far, far away….The Global Burden of Disease 2010 Study: what does it tell us about mental disorders in Latin America?Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010.The global burden of mental and substance use disorders: changes in estimating burden between GBD1990 and GBD2010.
P50
Q21245288-29E7D190-2F50-4169-A96B-B0723719DD19Q27860791-2276C381-CBA8-47E4-A557-78A065640BCEQ27860879-DFCBA077-F0F7-43A3-B005-DE6CDDB91CEAQ28111913-1DC0DDE6-17F4-4D31-909E-528FF09104CDQ30485861-3CFB6438-E86D-4186-9056-B03C04ABBBC9Q33763161-60B59A75-6EAE-4154-81A5-0533B37B2DEDQ33888699-5EB203EC-F48C-4B39-8327-3E382710440CQ34103927-86DC01DF-AC10-4A5D-B59A-382E81FA9122Q34795641-B916C41E-CFC1-4172-BD14-E7E0BA4BF8A6Q35138239-F9B444AA-AA2C-4213-8367-8085B1D52320Q36376732-336CE710-B5E4-46C5-AEA9-CB704955B73EQ36901241-C9F94C2E-CA8A-4E45-B52C-81CD4DA456D9Q36914278-250EF4C4-B847-4BD8-B270-AAC33BE6D6EFQ38025253-86A153ED-E128-4A19-BFF0-07E3518C9517Q38029431-A34883B7-0EF6-433F-B729-E9AE50BCFF23Q38108157-AE7013B7-51A7-49A8-89D2-EF769CAE6565Q38133045-A122A140-094B-4861-8A97-C396334C24B9Q38133047-ACDDB83A-AAF0-45B0-9B78-DF66AD474EE1Q38180616-072B59CA-2D60-47AA-8A2B-CB70429B5EABQ38180929-E06377DC-C810-4510-BE98-8BA434341C93Q38190139-6DD042E4-F23A-4BA0-AAAC-80D8D9D1135FQ38238436-F67B201D-38B0-40E2-AE00-FC5419D0CC41Q38388831-EA114D18-CD32-47F5-A52B-CD3884871C45Q39156069-07692FAC-D954-41E5-B3AF-5FA5814A6462Q41146685-03381103-BCD0-45EB-8232-86F005EB23D7Q42338332-058FC3A0-F080-4249-A419-D175949AD394Q46819034-B6917DD5-F5E1-4AAA-96F2-D1066588E8E0Q50606762-183C9CF2-238F-414A-8E04-A1B512D82772Q50647404-1D943FA0-4EA7-4D53-B15C-4F993919296C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Amanda Baxter
@ast
Amanda Baxter
@en
Amanda Baxter
@es
Amanda Baxter
@nl
Amanda Baxter
@sl
type
label
Amanda Baxter
@ast
Amanda Baxter
@en
Amanda Baxter
@es
Amanda Baxter
@nl
Amanda Baxter
@sl
altLabel
Baxter A
@en
Baxter AJ
@en
prefLabel
Amanda Baxter
@ast
Amanda Baxter
@en
Amanda Baxter
@es
Amanda Baxter
@nl
Amanda Baxter
@sl
P1053
E-5449-2011
P106
P21
P31
P3829
P496
0000-0001-8198-9022